Condition: Atrial Fibrillation · Cardiac Arrhythmia · Sponsor: University Hospital, Basel, Switzerland
The purpose of this study is to investigate whether a 3 month treatment course of low-dose Colchicine decreases the recurrence of Atrial fibrillation (AF) after electrocardioversion (ECV) in patients with AF.
This description comes directly from the study's public registry record.
Philipp Krisai, PD Dr. med. · +41 61 265 25 25 · Philipp.krisai@usb.ch
Always discuss trial participation with your own doctor first.
| Cantonal Hospital Baselland (KSBL) | Bruderholz, Basel-Landschaft, Switzerland | Recruiting |
| University Hospital Basel | Basel, Switzerland | Recruiting |
| University Hospital Bern | Bern, Switzerland | Recruiting |
| Lausanne University Hospital | Lausanne, Switzerland | Recruiting |
| Lucerne Cantonal Hospital | Lucerne, Switzerland | Recruiting |
| Cantonal Hospital Olten | Olten, Switzerland | Recruiting |
| Herzpraxis am Rhein | Rheinfelden, Switzerland | Recruiting |
| Solothurner Spitäler AG | Solothurn, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05890664